Biomedical technology

Do at-home COVID-19 tests expire?

Perhaps you stocked up when at-home COVID-19 test kits were hard to come by, before the U.S. federal government started a program to mail some to each household. Or maybe you found a bunch of test kits for a good price at ...

Alzheimer's disease & dementia

FDA OKs marketing of new test to help diagnose Alzheimer's disease

The U.S. Food and Drug Administration granted marketing approval for the Lumipulse G β-Amyloid Ratio (1-42/1-40) test, the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease, ...

Medications

Protein contributes to drug tolerance in tuberculosis

Weill Cornell Medicine researchers have identified a protein in Mycobacterium tuberculosis (Mtb) that contributes to drug tolerance, a phenomenon that allows bacteria to survive treatment with drugs that would normally kill ...

Diseases, Conditions, Syndromes

FDA warns of counterfeit home COVID-19 test kits

The U.S. Food and Drug Administration is warning Americans to watch out for phony at-home, over-the-counter COVID-19 tests that look a lot like the real things.

Obstetrics & gynaecology

FDA warns about genetic noninvasive prenatal screening tests

Noninvasive prenatal screening (NIPS) tests may yield false results or inappropriate interpretations of results, according to a safety communication issued by the U.S. Food and Drug Administration.

Medications

WHO 'strongly recommends' Pfizer's COVID pill

The World Health Organization said Friday it "strongly recommended" Pfizer's COVID-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalization.

Health informatics

Using convolutional neural networks to analyze medical imaging

COVID-19 remains a significant challenge the world over. Research in the International Journal of Computational Biology and Drug Design, discusses how X-ray images and CT (computerized tomography) scans can reveal much about ...

page 12 from 40